| Particulars |
|
|
|
| Company Name
| Remus Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
11.78 |
B.V. (₹) |
205.60 |
| Sales(₹ Cr.) |
79.16 |
NP (₹ Cr.) |
19.90 |
| NP Var (%) |
18.00 |
Div% |
0.00 |
| CPS(₹) |
18.50 |
EPS (₹) |
16.90 |
| Traded Value(₹ Lakhs) |
0.00 |
52 Week High |
1,417.00 |
| 52 Week Low |
891.00 |
Price BSE |
0.00 |
| Price NSE |
926.00 |
Market Capital (₹ Cr.) |
1,090.61 |
| P/C Ratio |
50.10 |
P/E Ratio |
54.80 |
| Price Vs.BV |
4.50 |
|
| Latest Quarter |
| Year End |
0 |
Sales (₹ Cr.) |
0.00 |
| NP(₹ Cr.) |
0.00 |
NP Var % |
0.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
0.00 |
| NP Var (%) |
18.42 |
EPS |
16.89 |
| PE |
54.80 |
|
|